GSK Q1 beats estimates

By Frank Prenesti

Date: Wednesday 26 Apr 2023

(Sharecast News) - GSK first quarter profits and revenue both beat expectations driven by its shingles and meningitis treatments, among others.
The company posted revenue of £7bn against expectations of £6.5bnm according to company-compiled estimates. Adjusted operating profit rose 8% to £2.1bn as GSK also maintained full-year guidance.

Its shingles vaccine, Shingrix, generated sales of £833m, beating estimates of £829m.

Reporting by Frank Prenesti for Sharecast.com

« Go back to news channel

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE